Sascha R A Alles Selected Research

Sascha R A Alles Research Topics

Disease

9	Neuralgia (Stump Neuralgia) 01/2022 - 02/2017
8	Pain (Aches) 12/2021 - 01/2018
6	Chronic Pain 01/2022 - 08/2020
2	Inflammation (Inflammations) 01/2022 - 08/2020
2	Neoplasms (Cancer) 08/2020 - 01/2018
1	Hyperalgesia 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 11/2021
1	Rheumatoid Arthritis 01/2021
1	Anosmia 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Hypoxia (Hypoxemia) 08/2020
1	Seizures (Absence Seizure) 01/2020
1	Epilepsy (Aura) 01/2020
1	Bone Neoplasms (Bone Cancer) 01/2018
1	Osteoarthritis 01/2018
1	Myalgia 01/2018
1	Migraine Disorders (Migraine) 01/2017
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2017

Drug/Important Bio-Agent (IBA)

6	Gabapentin (Neurontin)FDA LinkGeneric 11/2021 - 02/2017
6	Pregabalin (Lyrica)FDA Link 11/2021 - 01/2017
4	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2021
4	Voltage-Gated Sodium ChannelsIBA 01/2022 - 01/2020
3	Calcium Channels (Calcium Channel)IBA 12/2021 - 01/2020
2	Ion Channels (Ion Channel)IBA 01/2022 - 08/2020
2	Large Neutral Amino Acid-Transporter 1IBA 01/2022 - 08/2020
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2022 - 08/2020
2	AntibodiesIBA 12/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2020
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2018
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 01/2017
1	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022
1	Single-Chain AntibodiesIBA 12/2021
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	cercosporamideIBA 01/2021
1	Vorinostat FDA Link 01/2021
1	PF-05089771IBA 01/2021
1	6- amino- 5- (2,3,5- trichlorophenyl)pyridine- 2- carboxylic acid methylamideIBA 01/2021
1	Histone MethyltransferasesIBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	ezogabine (retigabine)IBA 01/2021
1	Arthropod VenomsIBA 01/2021
1	tanezumabIBA 01/2021
1	vixotrigineIBA 01/2021
1	A 803467IBA 01/2021
1	CationsIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	3,5- dichloro- N- (1- (2,2- dimethyltetrahydropyran- 4- ylmethyl)- 4- fluoropiperidin- 4- ylmethyl)benzamideIBA 01/2021
1	2- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 08/2020
1	endothelial PAS domain-containing protein 1IBA 08/2020
1	CateninsIBA 08/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 08/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Freund's AdjuvantIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	voltage-dependent calcium channel (P-Q type)IBA 01/2017
1	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 01/2017

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2017
1	Intraperitoneal Injections 12/2021
1	Analgesia 01/2021
1	Precision Medicine 01/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Ligation 01/2018